Earnings Report /

Genomma Lab Internacional: LAB, Quarterly Report 2Q21: High comparable base limits growth

  • Sales was supported by new product launches, development of its digital channel and an aggressive advertising campaign

  • Profitability was lower than expected as margin pressures in the US and Latam offset the expansion in Mexico

  • The normalization in the comparative base and the progressive start-up of its plant support a favorable outlook

Marissa Garza Ostos
Marissa Garza Ostos

Head of Equity Research

Juan Barbier
Juan Barbier

Equity Research Analyst

3 August 2021
Published by